The Information for the Dosing of Medicinal Products in Different Age Intervals Is Ambiguous.
Nika ZidaričSamo KreftPublished in: Therapeutic innovation & regulatory science (2018)
A need exists to develop a new, unambiguous style to present this information and prevent suboptimal dosing of drug with a lack of efficacy or additional risks of adverse effects.